FDA launches new priority review voucher program for select biopharmas

BRCA1

Breast Cancer Cells
Research

New discovery could open up PARP inhibitors to more patients

UT Southwestern researchers uncovered a mechanism by which PARP inhibitors attack cancer, suggesting they could be used in more patients.
Amirah Al Idrus Jul 24, 2019 11:00am
cancer

Could even more cancer patients benefit from PARP inhibitors?

Jul 16, 2018 12:37pm